Mark Kockx

Founder, Chief Executive Officer & Chief Medical Officer, Histogenex Laboratories, Antwerpen, Belgium.

Content by Mark Kockx:

Diagnostics Companion diagnostics

Improving Patient Outcomes

07/04/2019 | Eslie Dennis, Eric Walk, Ken Bloom, Mark Kockx

A response to David Rimm’s letter that supports the role of PD-L1 testing in improving outcomes for cancer patients.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Pathologist magazine